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create a niche for M. tuberculosis (10).
Our hypothesis could be refuted or
corroborated in several ways, for
example, by a case-control study of
HIV-negative patients infected with
tuberculosis. If this study refutes our
hypothesis, the idea that sex hor-
mones play a direct role in the
immune response to M. tuberculosis
would be supported. Such findings
might also provide possibilities for
drug development. However, if case-
control studies support our hypothe-
sis, attempts should be made to iden-
tify the pathogen. 
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To the Editor: Detection of new
bacteria, human complex microflora,
by using 16S rRNA gene amplifica-
tion and sequencing has been reported
(1). 16S rRNAgene amplification and
sequencing detected pyosalpinx,
caused by Leptotrichia amnioni, in a
patient whose samples were culture-
negative.
This anaerobic gram-negative bac-
terium has been isolated only
once before (2). A41-year-old woman
from the island of Comoros who had
been having lower abdominal pain for
6 days was admitted to the emergency
department of Hôpital Nord in
Marseille. The patient’s history
included type 2 diabetes mellitus
treated by metformin and laparoscopy
to explore infertility. On examination,
the patient had a pulse rate of 90 beats
per min, a blood pressure of 130/80
mm Hg, and a temperature of 38.5°C.
Her abdomen was not distended, but
diffused lower abdominal tenderness,
especially at the right iliac fossa, was
present. Blood testing showed
a leukocyte count of 7.7x109/L,
hemoglobin of 13.1g/dL, and platelet
count of 213x109/L. The chemistry
panel showed hyperglycemia (14.1
mmol/L) and elevated C-reactive pro-
tein (254 mg/L). Renal and liver func-
tion test results were all within normal
limits. Serum β-human chorionic
gonadotropin was negative. A com-
puted tomographic scan of the
abdomen and pelvis showed two sep-
tated adnexal masses, a 12x7x5 cm
mass on the right and a 6x4x2 cm
mass on the left; the patient was
referred to the gynecologic surgery
department. Gynecologic examina-
tion showed greenish, purulent vagi-
nal discharge and a fluctuant mass in
the pouch of Douglas. Uterine cervi-
cal motion caused pain to the patient.
Transabdominal and transvaginal
ultrasound scan showed a 10x7x5 cm
homogeneous liquid mass in the
pouch of Douglas. 
The patient was taken to the oper-
ating room and prepared for surgery.
The gynecologic team performed a
laparotomy that showed a 5-cm, left
hydrosalpinx and a 10-cm, right
tuboovarian abscess adherent to the
uterus, sigmoid colon, pelvic side-
wall, and pouch of Douglas. The
appendix and other viscera were nor-
mal. The adhesiolysis led to the rup-
ture of the abscess and discharge of
clear greenish pus, a sample of which
was sent to the laboratory for culture.
Antimicrobial drug treatment was
started with intravenous cefazolin,
gentamicin, and metronidazole. On
the first postoperative day, the patient
was afebrile. Oral amoxicillin plus
clavulanic acid was administered for
15 days, and oral ciprofloxacin was
administered for 20 days. The patient
was discharged on day 7 of hospital-
ization and was well at the follow-up
examination 1 month later.
After Gram staining, a sample of
the abscess drainage was injected
onto Columbia agar with 5% sheep
blood (bioMerieux, Marcy l’etoile,
France) under 5% CO2 and anaerobic
atmosphere. Antimicrobial suscepti-
bility of the sample was tested by an
agar diffusion method (3). A drop of
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the sample was deposited on an agar
plate flooded with a suspension of a
antimicrobial susceptible strain of
Micrococcus luteus. After 24 h of
incubation at 37°C, presence of
antimicrobial activity in the sample
was evident by a visible area of
growth inhibition of M. luteus around
the sample. Procedures for DNA
extraction and16S rRNA gene ampli-
fication and sequencing have been
detailed (4).
Gram staining of the sample
showed numerous polymorpho-
nuclear leukocytes and gram-negative
bacteria. Culture of the sample
remained sterile after 20 days of incu-
bation, and antimicrobial susceptibili-
ty was found. The 16S rRNA gene
amplification and sequencing deter-
mined a 1,493 nucleotide sequence.
This sequence had 99.7% nucleotide
similarity with that of L. amnionii
(GenBank accession no. AY078425),
which corresponded to a difference of
4 nucleotide. The 16S rRNA gene
sequence of the detected bacterium
was deposited under accession no.
AY489565. L. amnionii was previous-
ly recovered in anaerobic culture of
the amniotic fluid of a woman after
intrauterine fetal demise (2). It was
isolated on blood and chocolate agar
under anaerobic conditions and
showed very small gray colonies of
<1 mm. This slow-growing bacterium
was lost after two subcultures, and no
isolate is available for further descrip-
tion (2). In that case and in the case
reported here, the patients had
uneventful recoveries after an amoxi-
cillin plus clavulanic acid antimicro-
bial regimen was given. This bacteri-
um and our isolate are related to, but
different from, L. sanguinegens.
Leptotrichia is a small genus
closely related to Fusobacterium and
comprises slow-growing, gram-nega-
tive, filamentous, anaerobic bacterial
flora of the oral cavity and genital
tract (5). Species included in the
genus are L. buccalis, L. trevisanii, L.
sanguinegens, and L. amnionii (2,6).
All Leptotrichia species are extremely
fastidious and cannot be grown easily
on conventional microbiologic media
or by conventional methods. As evi-
denced by sequences available in the
GenBank database, most of the 16S
rRNA gene sequences are from
cloned DNA from complex flora but
not from bacterial isolates.
Leptotrichia species has been suspect-
ed to play a role in periodontal dis-
ease. However, Leptotrichia species
have only been associated with seri-
ous systemic disease, usually in
immunocompromised patients (7,8).
Bacteremia caused by L. sanguine-
gens in pregnant women has also been
reported (9). More widespread use of
polymerase chain reaction amplifica-
tion and sequencing of the 16S rRNA
gene for identification or detection of
fastidious pathogens in humans will
likely provide verification of several
new pathogens that are now part of
normal human flora. 
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To the Editor: Cholera outbreaks
caused by toxigenic Vibrio cholerae
serogroup O1 frequently occur in
many sub-Saharan African countries.
The serogroup O1 is classified into
two biotypes, classical and El Tor.
The seventh and current pandemic of
cholera is caused by the El Tor bio-
type; the classical biotype is believed
to be extinct. The classical and El Tor
biotypes of V. cholerae O1 are closely
related in their O-antigen biosynthetic
genes but differ in other regions of the
genome. The genomic structure of the
CTXΦ filamentous phage (1), in
which the cholera toxin genes are con-
tained, differs between the classical
and El Tor biotypes. CTXclassΦ is
found in classical strains, CTXETΦ is
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